Health and Human Services Secretary Robert F. Kennedy Jr. is targeting the government’s Vaccine Injury Compensation Program, without which manufacturers might cease producing shots.

In a Goliath-versus-David fight, UnitedHealth Group’s pharmacy benefit manager, Optum Rx, has filed lawsuits in five counties ...

Kentucky Gov. Andy Beshear, a Democrat, announced Monday that bromazolam, aka "Designer Xanax," has been reclassified as a Schedule 1 drug. Other states making news: Connecticut, North Carolina, ...

The system, from Signos, offers three- and six-month plans ($139 and $129 a month, respectively), and the company will send all of the continuous glucose monitors a patient needs, CNBC reported. Plus: ...

Although there are no specific FDA-approved drugs in the U.S. to treat the parasite, the emergency authorization paves the way for the use of animal drug products approved for other purposes or ...

After the American Academy of Pediatrics broke with HHS guidance, Secretary Robert F. Kennedy Jr. accused the group of being in the pocket of pharmaceutical companies. AAP says its guidance is based ...

A report by the Business Group on Health showing health care costs projected to rise 9% in 2026 has caused companies to reevaluate benefits and contracts for the coming year. A survey shows 66% of ...

Meanwhile, Iowa Medicaid work requirements are set to go into effect in January. Also: the impact of Medicaid cuts on Black children; provider reimbursement rate cuts in North Carolina; and more.

LGBTQ+ youth lost dedicated support on the 988 Suicide & Crisis Lifeline in July at a critical time. Advocates say mental ...

Doctors and public health leaders, including at the Centers for Disease Control and Prevention, recommend that most people 6 ...

The state is using an old source of funding to pay for a new money crunch: assisting out-of-state patients with the costs ...

We do believe that people who face high out-of-pocket costs need more options,” said Kevin Donahoe, diabetes marketing chief for Novo Nordisk. Plus: a look at the drugmaker's alliance with GoodRx; how ...